COMMUNIQUÉS West-GlobeNewswire

VitalHub Files Preliminary Base Shelf Prospectus
16/06/2025
TORONTO, June 16, 2025 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX: VHI) (OTCQX: VHIBF) (the “Company” or “VitalHub”) announces that today it has filed and obtained a receipt for a preliminary short form base shelf [...]
NOTICE TO DISREGARD -- Ministry of Health Saudi Arabia
16/06/2025
BOSTON, June 16, 2025 (GLOBE NEWSWIRE) -- We are advised by Ministry of Health Saudi Arabia that journalists and other readers should disregard the news release, "Saudia Arabia Introduces Strategic Healthcare Vision and [...]
Elizabeth Holmes Is in Prison But 'Theranos 2.0' Just Hit the Market
16/06/2025
“You Cannot Silence the Science,” Says Theranos and Blue Magic Inventor PALM BEACH, Fla., June 16, 2025 (GLOBE NEWSWIRE) -- Elizabeth Holmes may be behind bars, but the vision she once promoted, a world where blood [...]
FibroBiologics Closes Third $5 Million Tranche of $25 Million Financing
16/06/2025
HOUSTON, June 16, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 275+ patents issued and pending with a focus on the development of [...]
Castle Biosciences Enters Collaboration and License Agreement with SciBase to Develop Diagnostic Tests for Dermatologic Diseases
16/06/2025
Initial Development Project Targets Predicting Flares in Patients Diagnosed with Atopic Dermatitis FRIENDSWOOD, Texas, June 16, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving [...]
Streamline Health® Reports Fiscal First Quarter 2025 Financial Results
16/06/2025
ATLANTA, June 16, 2025 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (“Streamline” or the “Company”) (Nasdaq: STRM) , a leading provider of solutions that enable healthcare providers to proactively address [...]
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
16/06/2025
DUBLIN, June 16, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, today announced that the Compensation Committee of Avadel’s Board of [...]
Dyne Therapeutics to Host Investor Conference Call and Webcast to Provide Update on DYNE-101 for Myotonic Dystrophy Type 1, Tomorrow Tuesday, June 17 at 8:00 a.m. ET
16/06/2025
WALTHAM, Mass., June 16, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc . (Nasdaq: DYN), a clinical-stage neuromuscular disease company focused on advancing innovative life-transforming therapeutics for people living [...]
TLI Executive Director Featured in Medical Economics: New Article Highlights Innovations In Autism Care Models
16/06/2025
MCLEAN, Va., June 16, 2025 (GLOBE NEWSWIRE) -- The Thought Leadership & Innovation Foundation (TLI) proudly announces the publication of a new article by Executive Director Shawn Murphy in Medical Economics , titled [...]
Biocodex Microbiota Foundation invites Canadian academics and scientists to apply for €35,000 research grant
16/06/2025
The objective is to advance microbiota’s role study in human health & diseases MONTREAL, June 16, 2025 (GLOBE NEWSWIRE) -- The Biocodex Microbiota Foundation , an organization founded by Biocodex and dedicated to [...]
La Fondation du Microbiote de Biocodex invite les universitaires et scientifiques canadiens à soumettre leur candidature pour une bourse de recherche de 35 000 €
16/06/2025
L’objectif est de faire progresser l’étude du rôle du microbiote sur la santé et les maladies humaines MONTRÉAL, 16 juin 2025 (GLOBE NEWSWIRE) -- La Fondation du Microbiote de Biocodex , une organisation fondée par [...]
The Association of American Physicians and Surgeons files an Amicus Brief in the Supreme Court in Support of the Right to Conversion Therapy
16/06/2025
TUCSON, Ariz., June 16, 2025 (GLOBE NEWSWIRE) -- The Association of American Physicians and Surgeons (AAPS) filed its amicus brief in the U.S. Supreme Court on June 12 against a Colorado ban on conversion therapy for [...]
MediPharm Cautions Shareholders To Await Final Results of Annual and Special Meeting
16/06/2025
TORONTO, June 16, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“ MediPharm ” or the “ Company ”), a pharmaceutical company specialized in precision-based cannabinoids, wishes to [...]
Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting
16/06/2025
NEW HAVEN, Conn., June 16, 2025 (GLOBE NEWSWIRE) -- Management of specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) is requesting that shareholders instruct their brokers to vote their shares [...]
Procès-verbal de l'Assemblée Générale Ordinaire d'IBA et résultats des votes
16/06/2025
Information réglementée Assemblée Générale Ordinaire du 11 juin 2025 Belgique, le 16 juin 2025 ( 17h50 ) – Ion Beam Applications SA (« IBA ») annonce que l’ensemble des résolutions proposées à ses actionnaires lors de l [...]
FibroBiologics to Present at the BIO International Convention 2025
16/06/2025
HOUSTON, June 16, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 275+ patents issued and pending with a focus on the development of [...]
BioAro Launches PanOmiQ™ Research in Breakthrough for AI-Driven Drug Discovery and Multi-Omics
16/06/2025
AI meets genomics in BioAro’s latest launch, unlocking faster, scalable drug discovery. PanOmiQ™ Research sets a new global benchmark for precision health innovation. BOSTON, June 16, 2025 (GLOBE NEWSWIRE) -- BIO [...]
Inquis Medical’s AVENTUS Thrombectomy System Receives FDA 510(k) Clearance for Treatment of Pulmonary Embolism
16/06/2025
Pioneering device combines precision clot removal with autologous blood reinfusion to address unmet needs in PE treatment MENLO PARK, Calif., June 16, 2025 (GLOBE NEWSWIRE) -- Inquis Medical , the leading innovator in [...]
Transactions in Connection with Share Buy-back Program
16/06/2025
Company Announcement COPENHAGEN, Denmark; June 16, 2025 – Genmab A/S (Nasdaq: GMAB). On March 25, 2025, Genmab announced the initiation of a share buy-back program to repurchase up to 2.2 million shares to reduce [...]

Pages